Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-15-001825
Filing Date
2015-03-17
Accepted
2015-03-17 09:25:00
Documents
1
Period of Report
2012-12-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3122812nicholson_actinium.html 3  
1 OWNERSHIP DOCUMENT f3122812nicholson_actinium.xml 3 5971
  Complete submission text file 0001213900-15-001825.txt   7510
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 103 CHILDS ROAD BASKIN RIDGE NJ 07092
Business Address
Nicholson, C. David (Reporting) CIK: 0001636168 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36374 | Film No.: 15705008